Potential Sale Propels This Stock

By George Banko

April 19, 2022

Good morning Wake-Up Watch Listers! While you’re dipping that donut in your dark roast coffee you’ll see stock futures are unsettled as investors wait on a wave of corporate earnings reports. Will these reports help markets break out of a recent rut? We’ll know more soon.

But for now, here’s a look at the top-moving stocks this morning.

Zendesk (NYSE: ZEN)

Zendesk is up 6.61% premarket after the company announced it’s exploring a potential sale. The San Francisco-based company has a new adviser in Qatalyst Partners and has reached out to potential buyers. These include software companies and private equity firms. No final decision has been made at this time. Zendesk is stock to keep an eye on.

General Dynamics Corp. (NYSE: GD)

General Dynamics is up 1.93% premarket after Huntington Ingalls Industries Inc., (NYSE: HII) recently secured a modification contract involving the DDG 51 Class Destroyer program. The award was offered by the Naval Sea Systems Command in Washington D.C. The global naval vessels market’s worth is expected to increase $253 billion during the 2022-2031 period. This should also benefit shipbuilding companies like General Dynamics and Bae Systems (BAESY). General Dynamics Corp. is trending up.

There’s another aviation and defense stock that could see tremendous gains in the near future. It’s known as the ‘Last Great Value Stock’ and right now it’s trading for under $2. You’ll have to act fast if you want in though. There’s an upcoming announcement on May 12 that could send this stock soaring. Click here to unlock this stock.

Signature Bank (Nasdaq: SBNY)

Signature Bank is up 4.27% premarket after reporting strong first quarter earnings. The New York-based bank increased its net income from $148 million to a record $338.5 million. Total deposits also grew from $3.02 billion to $109.16 billion and average deposits increased to $5.28 billion. Signature Bank is looking strong right now.

Johnson & Johnson (NYSE: JNJ)

Johnson & Johnson is down 3.19% premarket as the company will announce earnings this morning. The stock fell 3% last January after the company missed revenue estimates for the fourth quarter. The company also recently agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid addiction crisis in the state. Johnson & Johnson is a stock to be cautious of going forward.

Moderna (Nasdaq: MRNA)

Moderna is down 2.36% premarket after the company reported concerning side effects for its experimental flu vaccine. The COVID-19 treatment space is also getting more crowded by the day, meaning Moderna will face a more challenging landscape to establish itself as a key player in booster shots. Moderna could be in for a rocky future.